Your browser doesn't support javascript.
loading
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum ß-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model.
VanScoy, B D; Jones, S; Conde, H; Friedrich, L V; Cotroneo, N; Bhavnani, S M; Ambrose, P G.
Affiliation
  • VanScoy BD; Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
  • Jones S; Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
  • Conde H; Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
  • Friedrich LV; Spero Therapeutics, Inc., Cambridge, Massachusetts, USA.
  • Cotroneo N; Spero Therapeutics, Inc., Cambridge, Massachusetts, USA.
  • Bhavnani SM; Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
  • Ambrose PG; Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
Antimicrob Agents Chemother ; 67(3): e0090822, 2023 03 16.
Article in En | MEDLINE | ID: mdl-36757190
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Beta-Lactams / Escherichia coli Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Beta-Lactams / Escherichia coli Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2023 Type: Article Affiliation country: United States